Literature DB >> 11590976

Long-term treatment with clozapine in an adult with autistic disorder accompanied by aggressive behaviour.

G Gobbi, L Pulvirenti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11590976      PMCID： PMC167190     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  14 in total

1.  Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study.

Authors:  P B Bergqvist; J Dong; P Blier
Journal:  Psychopharmacology (Berl)       Date:  1999-03       Impact factor: 4.530

2.  Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study.

Authors:  M N Potenza; J P Holmes; S J Kanes; C J McDougle
Journal:  J Clin Psychopharmacol       Date:  1999-02       Impact factor: 3.153

3.  Clinical effects of clozapine on autistic disorder.

Authors:  A Zuddas; M G Ledda; A Fratta; P Muglia; C Cianchetti
Journal:  Am J Psychiatry       Date:  1996-05       Impact factor: 18.112

Review 4.  The serotonin system in autism.

Authors:  E H Cook; B L Leventhal
Journal:  Curr Opin Pediatr       Date:  1996-08       Impact factor: 2.856

5.  Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys.

Authors:  D C Chugani; O Muzik; R Rothermel; M Behen; P Chakraborty; T Mangner; E A da Silva; H T Chugani
Journal:  Ann Neurol       Date:  1997-10       Impact factor: 10.422

Review 6.  The role of typical and atypical antipsychotic medications in the management of agitation and aggression.

Authors:  P F Buckley
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

7.  An open comparison of clozapine and risperidone in treatment-resistant schizophrenia.

Authors:  S W Flynn; G W MacEwan; S Altman; L C Kopala; D H Fredrikson; G N Smith; W G Honer
Journal:  Pharmacopsychiatry       Date:  1998-01       Impact factor: 5.788

8.  Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.

Authors:  S Kapur; R B Zipursky; G Remington
Journal:  Am J Psychiatry       Date:  1999-02       Impact factor: 18.112

9.  Clinical and neurocognitive effects of clozapine and risperidone in treatment-refractory schizophrenic patients: a prospective study.

Authors:  J P Lindenmayer; A Iskander; M Park; F S Apergi; P Czobor; R Smith; D Allen
Journal:  J Clin Psychiatry       Date:  1998-10       Impact factor: 4.384

10.  Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors.

Authors:  R Corbett; F Camacho; A T Woods; L L Kerman; R J Fishkin; K Brooks; R W Dunn
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530
View more
  8 in total

1.  Rescue of social behavior impairment by clozapine and alterations in the expression of neuronal receptors in a rat model of neurodevelopmental impairment induced by GRPR blockade.

Authors:  Juliana Presti-Torres; Vanessa Athaíde Garcia; Arethuza Dornelles; Luís Henrique Halmenschlager; Luisa Azambuja Alcalde; Gustavo Vedana; Eduardo Pacheco Rico; Maurício Reis Bogo; Gilberto Schwartsmann; Rafael Roesler; Nadja Schröder
Journal:  J Neural Transm (Vienna)       Date:  2011-08-17       Impact factor: 3.575

Review 2.  Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders.

Authors:  Richard P Malone; Silvia S Gratz; Mary Anne Delaney; Susan B Hyman
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 3.  A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder.

Authors:  Sushmitha S Purushotham; Neeharika M N Reddy; Michelle Ninochka D'Souza; Nilpawan Roy Choudhury; Anusa Ganguly; Niharika Gopalakrishna; Ravi Muddashetty; James P Clement
Journal:  Exp Brain Res       Date:  2022-09-05       Impact factor: 2.064

Review 4.  Antipsychotics in the treatment of autism.

Authors:  David J Posey; Kimberly A Stigler; Craig A Erickson; Christopher J McDougle
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 5.  Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders.

Authors:  Laura C Politte; Christopher J McDougle
Journal:  Psychopharmacology (Berl)       Date:  2013-04-04       Impact factor: 4.530

Review 6.  Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.

Authors:  Carolyn A Doyle; Christopher J McDougle
Journal:  Dialogues Clin Neurosci       Date:  2012-09       Impact factor: 5.986

Review 7.  Aggression in autism spectrum disorder: presentation and treatment options.

Authors:  Sarah E Fitzpatrick; Laura Srivorakiat; Logan K Wink; Ernest V Pedapati; Craig A Erickson
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-23       Impact factor: 2.570

Review 8.  Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder.

Authors:  Nermin Eissa; Mohammed Al-Houqani; Adel Sadeq; Shreesh K Ojha; Astrid Sasse; Bassem Sadek
Journal:  Front Neurosci       Date:  2018-05-16       Impact factor: 4.677
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.